8-K

Current Report

Compass Therapeutics, Inc. Filed 2020-06-23 Acc 0001213900-20-015594

Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change

Item 1.01 Entry into a material definitive agreement
Item 2.01 Completion of acquisition or disposition of assets
Item 3.02 Unregistered sales of equity securities
Item 4.01 Changes in the registrant's certifying accountant
Item 5.01 Changes in control of the registrant
Item 5.02 Departure or appointment of directors or officers
Item 5.03 Amendments to articles or bylaws; change in fiscal year
Item 5.06 Change in shell company status

From the SEC's structured data for this filing